B. Hong

发表

Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1.

G. Mills, Yiling Lu, S. Cheng, 2010, Biochemical pharmacology.

FGF8b oncogene mediates proliferation and invasion of Epstein–Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation

S. Tsao, P. Ng, C. Tsang, 2011, Oncogene.

Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death

G. Mills, S. Tsui, T. Mok, 2011, Oncogene.

An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation.

S. Cheng, C. Tsang, Y. Yamasaki, 2010, Biochemical pharmacology.

Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells.

S. Tsao, C. Tsang, A. Chan, 2009, Carcinogenesis.

Targeting tumor hypoxia in nasopharyngeal carcinoma

E. Hui, A. Chan, V. W. Lui, 2013, Head & neck.

Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation

S. Tsao, S. Cheng, C. Tsang, 2011, Investigational New Drugs.

STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro

J. Grandis, Q. Tao, S. Tsao, 2009, International journal of cancer.